Evropska unija - estonščina - EMA (European Medicines Agency)

astellas pharma europe b.v. - enfortumab vedotin - carcinoma, transitional cell; urologic neoplasms - antineoplastilised ained - padcev as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and a programmed death receptor 1 or programmed death ligand 1 inhibitor.

Estonija - estonščina - Ravimiamet

actavis group ptc ehf. - valatsikloviir - õhukese polümeerikattega tablett - 250mg 50tk; 250mg 90tk; 250mg 10tk; 250mg 14tk; 250mg 60tk; 250mg 42tk

Estonija - estonščina - Ravimiamet

teva b.v. - valatsikloviir - õhukese polümeerikattega tablett - 500mg 60tk; 500mg 24tk; 500mg 50tk; 500mg 3tk; 500mg 10tk; 500mg 20tk; 500mg 42tk

Estonija - estonščina - Ravimiamet

first pharma oÜ - valatsikloviir - õhukese polümeerikattega tablett - 500mg 42tk; 500mg 90tk; 500mg 24tk; 500mg 112tk; 500mg 30tk

Estonija - estonščina - Ravimiamet

glaxosmithkline (ireland) limited - valatsikloviir - õhukese polümeerikattega tablett - 500mg 30tk; 500mg 10tk; 500mg 42tk; 500mg 24tk; 500mg 112tk; 500mg 90tk

Estonija - estonščina - Ravimiamet

accord healthcare b.v. - furosemiid - süste-/infusioonilahus - 10mg 1ml 4ml 5tk; 10mg 1ml 4ml 10tk; 10mg 1ml 2ml 5tk; 10mg 1ml 2ml 10tk; 10mg 1ml 25ml 5tk; 10mg 1ml 5ml 5tk; 10mg 1ml 4ml 1tk; 10mg 1ml 25ml 10tk; 10mg 1ml 25ml 1tk

Estonija - estonščina - Ravimiamet

teva b.v. - valatsikloviir - õhukese polümeerikattega tablett - 1000mg 3tk; 1000mg 28tk; 1000mg 50tk; 1000mg 20tk; 1000mg 14tk; 1000mg 90tk; 1000mg 10tk; 1000mg 24tk; 1000mg 42tk; 1000mg 60tk; 1000mg 7tk

Estonija - estonščina - Ravimiamet

ideal trade links uab - valatsikloviir - õhukese polümeerikattega tablett - 500mg 10tk

Estonija - estonščina - Ravimiamet

lex ano uab - valatsikloviir - õhukese polümeerikattega tablett - 500mg 10tk

Estonija - estonščina - Ravimiamet

lex ano uab - valatsikloviir - õhukese polümeerikattega tablett - 500mg 10tk